Agilent Technologies, Inc. $A Shares Sold by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA trimmed its holdings in Agilent Technologies, Inc. (NYSE:A) by 16.0% during the third quarter, Holdings Channel reports. The institutional investor owned 3,774,483 shares of the medical research company’s stock after selling 719,828 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Agilent Technologies were worth $650,402,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. State Street Corp raised its position in Agilent Technologies by 0.7% in the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock valued at $1,710,658,000 after buying an additional 89,598 shares during the last quarter. Wellington Management Group LLP grew its position in Agilent Technologies by 2.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock worth $990,206,000 after purchasing an additional 198,253 shares in the last quarter. Deutsche Bank AG grew its holdings in shares of Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after acquiring an additional 1,024,516 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after buying an additional 2,440,360 shares during the last quarter. Finally, Legal & General Group Plc purchased a new stake in Agilent Technologies during the second quarter worth about $260,101,000.

Insider Buying and Selling at Agilent Technologies

In related news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. This trade represents a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $174.79 on Friday. The company has a market capitalization of $49.28 billion, a PE ratio of 34.41, a P/E/G ratio of 2.56 and a beta of 1.24. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $182.99. The firm has a fifty day simple moving average of $165.94 and a two-hundred day simple moving average of $137.20. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period last year, the company earned $1.37 EPS. Agilent Technologies’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were issued a dividend of $0.2550 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is currently 20.08%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on A shares. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, October 17th. Evercore raised their price objective on shares of Agilent Technologies from $148.00 to $178.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Piper Sandler boosted their price objective on shares of Agilent Technologies from $150.00 to $160.00 and gave the company a “neutral” rating in a research note on Friday, August 28th. UBS Group upped their target price on shares of Agilent Technologies from $165.00 to $180.00 in a report on Tuesday, October 13th. Finally, Stifel Nicolaus raised their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $181.45.

Agilent Technologies Company Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.